FNY Investment Advisers’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,500	Closed	-$6K	–	526
2023 Q1	$6K	Sell	4,500 -60,500	-93%	-$80.7K	0.01%	368
2022 Q4	$104K	Buy	+65,000	New	+$104K	0.15%	132